These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 12362226)

  • 61. Chromogenic substrate spectrophotometric assays for the measurement of clotting function.
    Aiyappa PA
    Ann N Y Acad Sci; 1981; 370():812-21. PubMed ID: 6943978
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Rare bleeding disorders in children: identification and primary care management.
    Acharya SS
    Pediatrics; 2013 Nov; 132(5):882-92. PubMed ID: 24127475
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Elevated thrombin generation in patients with congenital disorder of glycosylation and combined coagulation factor deficiencies.
    Pascreau T; de la Morena-Barrio ME; Lasne D; Serrano M; Bianchini E; Kossorotoff M; Boddaert N; Bruneel A; Seta N; Vicente V; de Lonlay P; Corral J; Borgel D
    J Thromb Haemost; 2019 Nov; 17(11):1798-1807. PubMed ID: 31271700
    [TBL] [Abstract][Full Text] [Related]  

  • 64. In vitro effects of human neutrophil cathepsin G on thrombin generation: Both acceleration and decreased potential.
    Perrin J; Lecompte T; Tournier A; Morlon L; Marchand-Arvier M; Vigneron C
    Thromb Haemost; 2010 Sep; 104(3):514-22. PubMed ID: 20589323
    [TBL] [Abstract][Full Text] [Related]  

  • 65. In vitro evaluation of residual procoagulants in human intravenous immunoglobulins from 11 Chinese blood fractionation companies.
    Ma L; Sun P; Lin F; Diao G; Li C
    Thromb Res; 2013 Sep; 132(3):381-5. PubMed ID: 23953595
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Assessment of laboratory assays to measure rivaroxaban--an oral, direct factor Xa inhibitor.
    Samama MM; Martinoli JL; LeFlem L; Guinet C; Plu-Bureau G; Depasse F; Perzborn E
    Thromb Haemost; 2010 Apr; 103(4):815-25. PubMed ID: 20135059
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Coagulation disorders and inhibitors of coagulation in children from Mansoura, Egypt.
    Abdelrazik N; Rashad H; Selim T; Tharwat L
    Hematology; 2007 Aug; 12(4):309-14. PubMed ID: 17654057
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A novel congenital dysprothrombinemia leading to defective prothrombin maturation.
    Bafunno V; Bury L; Tiscia GL; Fierro T; Favuzzi G; Caliandro R; Sessa F; Grandone E; Margaglione M; Gresele P
    Thromb Res; 2014 Nov; 134(5):1135-41. PubMed ID: 25242243
    [TBL] [Abstract][Full Text] [Related]  

  • 69. In vivo reversal of the anticoagulant effect of rivaroxaban with four-factor prothrombin complex concentrate.
    Barco S; Whitney Cheung Y; Coppens M; Hutten BA; Meijers JC; Middeldorp S
    Br J Haematol; 2016 Jan; 172(2):255-61. PubMed ID: 26488126
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Relationship between secretion of platelet Factor 4 and thrombin generation during in vitro blood clotting.
    Shuman MA; Levine SP
    J Clin Invest; 1980 Feb; 65(2):307-13. PubMed ID: 6243308
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Monitoring hypocoagulant conditions in rat plasma: factors determining the endogenous thrombin potential of tissue factor-activated plasma.
    Nieuwenhuys CM; Feijge MA; Béguin S; Heemskerk JW
    Thromb Haemost; 2000 Dec; 84(6):1045-51. PubMed ID: 11154112
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Evaluation of the Q analyzer, a new cap-piercing fully automated coagulometer with clotting, chromogenic, and immunoturbidometric capability.
    Kitchen S; Woolley A
    Blood Coagul Fibrinolysis; 2013 Jan; 24(1):28-34. PubMed ID: 23249565
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Factor XI enhances fibrin generation and inhibits fibrinolysis in a coagulation model initiated by surface-coated tissue factor.
    von dem Borne PA; Cox LM; Bouma BN
    Blood Coagul Fibrinolysis; 2006 Jun; 17(4):251-7. PubMed ID: 16651866
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Thrombin generation assessed as endogenous thrombin potential in patients with hyper- or hypo-coagulability.
    Chantarangkul V; Clerici M; Bressi C; Giesen PL; Tripodi A
    Haematologica; 2003 May; 88(5):547-54. PubMed ID: 12745274
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Challenges in the laboratory analyses of bleeding disorders.
    Chitlur M
    Thromb Res; 2012 Jul; 130(1):1-6. PubMed ID: 22483776
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Thrombin generation in patients after acute deep-vein thrombosis.
    ten Cate-Hoek AJ; Dielis AW; Spronk HM; van Oerle R; Hamulyák K; Prins MH; ten Cate H
    Thromb Haemost; 2008 Aug; 100(2):240-5. PubMed ID: 18690343
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Crossover dose escalation study to assess safety, pharmacokinetics, and pharmacodynamics of single doses of R1663, an oral factor Xa inhibitor, in healthy male volunteers.
    Schmitt C; Pannier A; McIntyre C; Zandt H; Ciorciaro C; Winters K; Pepper T
    J Clin Pharmacol; 2012 Apr; 52(4):499-510. PubMed ID: 21566199
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Can the diagnostic reliability of the thrombin generation test as a global haemostasis assay be improved? The impact of calcium chloride concentration.
    Parunov LA; Surov SS; Liang Y; Lee TK; Ovanesov MV
    Haemophilia; 2017 May; 23(3):466-475. PubMed ID: 28205396
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Plasmatic tissue factor pathway inhibitor is a major determinant of clotting in factor VIII inhibited plasma or blood.
    Knappe S; Gorczyca ME; Jilma B; Derhaschnig U; Hartmann R; Palige M; Scheiflinger F; Dockal M
    Thromb Haemost; 2013 Mar; 109(3):450-7. PubMed ID: 23348798
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Thrombin generation assays and their clinical application].
    Kern A; Várnai K; Vásárhelyi B
    Orv Hetil; 2014 Jun; 155(22):851-7. PubMed ID: 24860049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.